EW vs VCEL · P/E 47, rev $1.39B vs P/E 835, rev $237.2M
Edwards Lifesciences Corp (EW) versus Vericel Corp Ord (VCEL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Vericel Corp Ord (VCEL) is a biotechnology company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported VCEL revenue for 2024-12-31 was $237.2M. Net income was $10.4M. Revenue was up 20.1% from 2023-12-31 to 2024-12-31. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
Not investment advice. Open the EW and VCEL stock pages for the full models.
Not investment advice.